Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Itziar Etxeandia-Ikobaltzeta is active.

Publication


Featured researches published by Itziar Etxeandia-Ikobaltzeta.


Canadian Medical Association Journal | 2014

The validity of recommendations from clinical guidelines: a survival analysis

Laura Martínez García; Andrea Juliana Sanabria; Elvira García Álvarez; Maria Mar Trujillo-Martín; Itziar Etxeandia-Ikobaltzeta; Anna Kotzeva; David Rigau; Arturo Louro-González; Leticia Barajas-Nava; Petra Díaz del Campo; Maria-Dolors Estrada; Ivan Solà; Javier Gracia; Flavia Salcedo-Fernandez; Jennifer Lawson; R. Brian Haynes; Pablo Alonso-Coello

Background: Clinical guidelines should be updated to maintain their validity. Our aim was to estimate the length of time before recommendations become outdated. Methods: We used a retrospective cohort design and included recommendations from clinical guidelines developed in the Spanish National Health System clinical guideline program since 2008. We performed a descriptive analysis of references, recommendations and resources used, and a survival analysis of recommendations using the Kaplan–Meier method. Results: We included 113 recommendations from 4 clinical guidelines with a median of 4 years since the most recent search (range 3.9–4.4 yr). We retrieved 39 136 references (range 3343–14 787) using an exhaustive literature search, 668 of which were related to the recommendations in our sample. We identified 69 (10.3%) key references, corresponding to 25 (22.1%) recommendations that required updating. Ninety-two percent (95% confidence interval 86.9–97.0) of the recommendations were valid 1 year after their development. This probability decreased at 2 (85.7%), 3 (81.3%) and 4 years (77.8%). Interpretation: Recommendations quickly become outdated, with 1 out of 5 recommendations being out of date after 3 years. Waiting more than 3 years to review a guideline is potentially too long.


Health and Quality of Life Outcomes | 2017

Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach

Yuan Zhang; Pablo Alonso Coello; Jan Brozek; Wojtek Wiercioch; Itziar Etxeandia-Ikobaltzeta; Elie A. Akl; Joerg J. Meerpohl; Waleed Alhazzani; Alonso Carrasco-Labra; Rebecca L. Morgan; Reem A. Mustafa; John J. Riva; Ainsley Moore; Juan José Yepes-Nuñez; Carlos A. Cuello-Garcia; Zulfa AlRayees; Veena Manja; Maicon Falavigna; Ignacio Neumann; Romina Brignardello-Petersen; Nancy Santesso; Bram Rochwerg; Andrea Darzi; María Ximena Rojas; Yaser Adi; Claudia Bollig; Reem Waziry; Holger J. Schünemann

BackgroundThere are diverse opinions and confusion about defining and including patient values and preferences (i.e. the importance people place on the health outcomes) in the guideline development processes. This article aims to provide an overview of a process for systematically incorporating values and preferences in guideline development.MethodsIn 2013 and 2014, we followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to adopt, adapt and develop 226 recommendations in 22 guidelines for the Ministry of Health of the Kingdom of Saudi Arabia. To collect context-specific values and preferences for each recommendation, we performed systematic reviews, asked clinical experts to provide feedback according to their clinical experience, and consulted patient representatives.ResultsWe found several types of studies addressing the importance of outcomes, including those reporting utilities, non-utility measures of health states based on structured questionnaires or scales, and qualitative studies. Guideline panels used the relative importance of outcomes based on values and preferences to weigh the balance of desirable and undesirable consequences of alternative intervention options. However, we found few studies addressing local values and preferences.ConclusionsCurrently there are different but no firmly established processes for integrating patient values and preferences in healthcare decision-making of practice guideline development. With GRADE Evidence-to-Decision (EtD) frameworks, we provide an empirical strategy to find and incorporate values and preferences in guidelines by performing systematic reviews and eliciting information from guideline panel members and patient representatives. However, more research and practical guidance are needed on how to search for relevant studies and grey literature, assess the certainty of this evidence, and best summarize and present the findings.


The Lancet | 2017

Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis

Siddharth Nath; Alex Koziarz; Jetan H. Badhiwala; Waleed Alhazzani; Roman Jaeschke; Sunjay Sharma; Laura Banfield; Ashkan Shoamanesh; Sheila K. Singh; Farshad Nassiri; Wieslaw Oczkowski; Emilie P. Belley-Côté; Ray Truant; Kesava Reddy; Maureen O. Meade; Forough Farrokhyar; Malgorzata M Bala; Fayez Alshamsi; Mette Krag; Itziar Etxeandia-Ikobaltzeta; Regina Kunz; Osamu Nishida; Charles C. Matouk; Magdy Selim; Andrew Rhodes; Gregory W.J. Hawryluk; Saleh A. Almenawer

BACKGROUND Atraumatic needles have been proposed to lower complication rates after lumbar puncture. However, several surveys indicate that clinical adoption of these needles remains poor. We did a systematic review and meta-analysis to compare patient outcomes after lumbar puncture with atraumatic needles and conventional needles. METHODS In this systematic review and meta-analysis, we independently searched 13 databases with no language restrictions from inception to Aug 15, 2017, for randomised controlled trials comparing the use of atraumatic needles and conventional needles for any lumbar puncture indication. Randomised trials comparing atraumatic and conventional needles in which no dural puncture was done (epidural injections) or without a conventional needle control group were excluded. We screened studies and extracted data from published reports independently. The primary outcome of postdural-puncture headache incidence and additional safety and efficacy outcomes were assessed by random-effects and fixed-effects meta-analysis. This study is registered with the International Prospective Register of Systematic Reviews, number CRD42016047546. FINDINGS We identified 20 241 reports; after exclusions, 110 trials done between 1989 and 2017 from 29 countries, including a total of 31 412 participants, were eligible for analysis. The incidence of postdural-puncture headache was significantly reduced from 11·0% (95% CI 9·1-13·3) in the conventional needle group to 4·2% (3·3-5·2) in the atraumatic group (relative risk 0·40, 95% CI 0·34-0·47, p<0·0001; I2=45·4%). Atraumatic needles were also associated with significant reductions in the need for intravenous fluid or controlled analgesia (0·44, 95% CI 0·29-0·64; p<0·0001), need for epidural blood patch (0·50, 0·33-0·75; p=0·001), any headache (0·50, 0·43-0·57; p<0·0001), mild headache (0·52, 0·38-0·70; p<0·0001), severe headache (0·41, 0·28-0·59; p<0·0001), nerve root irritation (0·71, 0·54-0·92; p=0·011), and hearing disturbance (0·25, 0·11-0·60; p=0·002). Success of lumbar puncture on first attempt, failure rate, mean number of attempts, and the incidence of traumatic tap and backache did not differ significantly between the two needle groups. Prespecified subgroup analyses of postdural-puncture headache revealed no interactions between needle type and patient age, sex, use of prophylactic intravenous fluid, needle gauge, patient position, indication for lumbar puncture, bed rest after puncture, or clinician specialty. These results were rated high-quality evidence as examined using the grading of recommendations assessment, development, and evaluation. INTERPRETATION Among patients who had lumbar puncture, atraumatic needles were associated with a decrease in the incidence of postdural-puncture headache and in the need for patients to return to hospital for additional therapy, and had similar efficacy to conventional needles. These findings offer clinicians and stakeholders a comprehensive assessment and high-quality evidence for the safety and efficacy of atraumatic needles as a superior option for patients who require lumbar puncture. FUNDING None.


Health Research Policy and Systems | 2018

Development of rapid guidelines: 2. A qualitative study with WHO guideline developers

Ivan D. Florez; Rebecca L. Morgan; Maicon Falavigna; Sergio Kowalski; Yuan Zhang; Itziar Etxeandia-Ikobaltzeta; Nancy Santesso; Wojtek Wiercioch; Holger J. Schünemann

BackgroundSituations such as public health emergencies and outbreaks necessitate the development and publication of high-quality recommendations within a condensed timeframe. For example, WHO has produced examples of and guidance for the development of rapid guidelines (RGs). However, more information is needed to understand the experiences and perceptions of guideline developers. This is the second of a series of three articles addressing methodological issues around RGs. This study describes the perceptions and experiences of guideline developers at WHO about RGs.MethodsWe conducted interviews consisting of open- and closed-ended questions with guideline developers at WHO. Our analysis described the definition and rationale of RGs, the differences from regular guidelines with regard to timelines from topic definition until publication, barriers to identifying the evidence and the lack of a standard methodology to develop RGs.ResultsWe interviewed 10 participants, the majority of whom were comfortable with the current WHO definition of RGs. Most stated that the rationale for developing RGs should be in response to new evidence about efficacy, cost-effectiveness or safety. Respondents differed with regards to the amount of time RGs should take. While the majority of participants agreed that guidelines should be based on a systematic review, this step in the process was considered the most time and resource intensive. Challenges for developing RGs included limited personnel and financial resources as well as the lack of evidence. Facilitators, in turn, that may improve RG development include additional financial and personnel resources as well as the use of virtual meetings.ConclusionsWhile our study suggests a strong need and rationale for the development of RGs, standardisation of timelines and guidance on panel composition, peer-review process, conduct of meetings and sources of permissible evidence require further research.


Implementation Science | 2015

The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels

Ignacio Neumann; Romina Brignardello-Petersen; Wojtek Wiercioch; Alonso Carrasco-Labra; Carlos Cuello; Elie A. Akl; Reem A. Mustafa; Waleed Alhazzani; Itziar Etxeandia-Ikobaltzeta; María Ximena Rojas; Maicon Falavigna; Nancy Santesso; Jan Brozek; Alfonso Iorio; Pablo Alonso-Coello; Holger J. Schünemann

BackgroundJudgments underlying guideline recommendations are seldom recorded and presented in a systematic fashion. The GRADE Evidence-to-Decision Framework (EtD) offers a transparent way to record and report guideline developers’ judgments. In this paper, we report the experiences with the EtD frameworks in 15 real guideline panels.MethodsFollowing the guideline panel meetings, we asked methodologists participating in the panel to provide feedback regarding the EtD framework. They were instructed to consider their own experience and the feedback collected from the rest of the panel. Two investigators independently summarized the responses and jointly interpreted the data using pre-specified domains as coding system. We asked methodologists to review the results and provide further input to improve the structure of the EtDs iteratively.ResultsThe EtD framework was well received, and the comments were generally positive. Methodologists felt that in a real guideline panel, the EtD framework helps structuring a complex process through relatively simple steps in an explicit and transparent way. However, some sections (e.g., “values and preferences” and “balance between benefits and harms”) required further development and clarification that were considered in the current version of the EtD framework.ConclusionsThe use of an EtD framework in guideline development offers a structured and explicit way to record and report the judgments and discussion of guideline panels during the formulation of recommendations. In addition, it facilitates the formulation of recommendations, assessment of their strength, and identifying gaps in research.


Implementation Science | 2013

Strategies to assess the validity of recommendations: a study protocol.

Laura Martínez García; Andrea Juliana Sanabria; Ignacio Araya; Jennifer Lawson; R. Brian Haynes; David Rigau; Ivan Solà; Petra Díaz del Campo; Maria Dolors Estrada; Itziar Etxeandia-Ikobaltzeta; Elvira García Álvarez; Javier Gracia; Anna Kotzeva; Arturo Louro-González; Flavia Salcedo-Fernandez; Maria Mar Trujillo-Martín; Pablo Alonso-Coello

BackgroundClinical practice guidelines (CPGs) become quickly outdated and require a periodic reassessment of evidence research to maintain their validity. However, there is little research about this topic. Our project will provide evidence for some of the most pressing questions in this field: 1) what is the average time for recommendations to become out of date?; 2) what is the comparative performance of two restricted search strategies to evaluate the need to update recommendations?; and 3) what is the feasibility of a more regular monitoring and updating strategy compared to usual practice?. In this protocol we will focus on questions one and two.MethodsThe CPG Development Programme of the Spanish Ministry of Health developed 14 CPGs between 2008 and 2009. We will stratify guidelines by topic and by publication year, and include one CPG by strata.We will develop a strategy to assess the validity of CPG recommendations, which includes a baseline survey of clinical experts, an update of the original exhaustive literature searches, the identification of key references (reference that trigger a potential recommendation update), and the assessment of the potential changes in each recommendation.We will run two alternative search strategies to efficiently identify important new evidence: 1) PLUS search based in McMaster Premium LiteratUre Service (PLUS) database; and 2) a Restrictive Search (ReSe) based on the least number of MeSH terms and free text words needed to locate all the references of each original recommendation.We will perform a survival analysis of recommendations using the Kaplan-Meier method and we will use the log-rank test to analyse differences between survival curves according to the topic, the purpose, the strength of recommendations and the turnover. We will retrieve key references from the exhaustive search and evaluate their presence in the PLUS and ReSe search results.DiscussionOur project, using a highly structured and transparent methodology, will provide guidance of when recommendations are likely to be at risk of being out of date. We will also assess two novel restrictive search strategies which could reduce the workload without compromising rigour when CPGs developers check for the need of updating.


Journal of Clinical Epidemiology | 2018

GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences—inconsistency, imprecision, and other domains

Yuan Zhang; Pablo Alonso Coello; Gordon H. Guyatt; Juan José Yepes-Nuñez; Elie A. Akl; Glen S. Hazlewood; Hector Pardo-Hernandez; Itziar Etxeandia-Ikobaltzeta; Amir Qaseem; John W. Williams; Peter Tugwell; Signe Flottorp; Yaping Chang; Yuqing Zhang; Reem A. Mustafa; María Ximena Rojas; Feng Xie; Holger J. Schünemann

OBJECTIVE To provide Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) guidance for assessing inconsistency, imprecision, and other domains for the certainty of evidence about the relative importance of outcomes. STUDY DESIGN AND SETTING We applied the GRADE domains to rate the certainty of evidence in the importance of outcomes to several systematic reviews, iteratively reviewed draft guidance, and consulted GRADE members and other stakeholders for feedback. RESULTS We describe the rationale for considering the remaining GRADE domains when rating the certainty in a body of evidence for the relative importance of outcomes. As meta-analyses are not common in this context, inconsistency and imprecision assessments are challenging. Furthermore, confusion exists about inconsistency, imprecision, and true variability in the relative importance of outcomes. To clarify this issue, we suggest that the true variability is neither equivalent to inconsistency nor imprecision. Specifically, inconsistency arises from population, intervention, comparison and outcome and methodological elements that should be explored and, if possible, explained. The width of the confidence interval and sample size inform judgments about imprecision. We also provide suggestions on how to detect publication bias and discuss the domains to rate up the certainty. CONCLUSION We provide guidance and examples for rating inconsistency, imprecision, and other domains for a body of evidence describing the relative importance of outcomes.


Health Research Policy and Systems | 2018

Development of rapid guidelines: 1. Systematic survey of current practices and methods

Sergio Kowalski; Rebecca L. Morgan; Maicon Falavigna; Ivan D. Florez; Itziar Etxeandia-Ikobaltzeta; Wojtek Wiercioch; Yuan Zhang; Faria Sakhia; Liudmila Ivanova; Nancy Santesso; Holger J. Schünemann

BackgroundGuidelines in the healthcare field generally should contain evidence-based recommendations to inform healthcare decisions. Guidelines often require 2 years or more to develop, but certain circumstances necessitate the development of rapid guidelines (RGs) in a short period of time. Upholding methodological rigor while meeting the reduced development timeframe presents a challenge for developing RGs. Our objective was to review current practices and standards for the development of RGs. This is the first of a series of three articles addressing methodological issues around RGs.MethodsWe conducted a systematic survey of methods manuals and published RGs to identify reasons for the development of RGs. Data sources included existing guideline manuals, published RGs, Trip Medical Database, MEDLINE, EMBASE and communication with guideline developers until February 2018.ResultsWe identified 46 guidelines that used a shortened timeframe for their development. Nomenclature describing RGs varied across organisations, wherein the United States Centers for Disease Control and Prevention produced ‘Interim Guidelines’, the National Institute for Health and Care Excellence in the United Kingdom developed ‘Short Clinical Guidelines’, and WHO provided ‘Rapid Advice’. The rationale for RGs included response to emergencies, rapid increases in cases of a condition or disease severity, or new evidence regarding treatment. In general, the methods to assess the quality of evidence, the consensus process and the management of the conflict of interest were not always clear. While we identified another 11 RGs from other institutions, there was no reference to timeframe and reasons for conducting a RG. The three organisations mentioned above provide guidance for the development of RGs.ConclusionsThere is a lack of standardised nomenclature and definitions regarding RGs and there is inconsistency in the methods described in manuals and in RG. It is therefore important that all RGs provide a detailed and transparent description of their methods in order for readers and end-users to be able to assess their quality and validate their findings.


Medicina Clinica | 2016

Lista de comprobación del proceso de elaboración de guías de práctica clínica

Itziar Etxeandia-Ikobaltzeta; Romina Brignardello-Petersen; Alonso Carrasco-Labra; Pablo Alonso-Coello

[ 1 ] Gobierno Vasco Eusko Jaurlaritza, Direcc Invest & Innovac Sanitaria, Serv Evaluat Tecnol Sanitarias Pais Vasco Osteba, Vitoria, Alava Araba, Spain [ 2 ] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada [ 3 ] Univ Chile, Fac Odontol, Unidad Odontol Basada Evidencia, Santiago, Chile [ 4 ] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada [ 5 ] CIBERESP, IIB St Pau, Ctr Cochrane Iberoamer, Barcelona, Spain


The Journal of Allergy and Clinical Immunology | 2010

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan Brozek; Jean Bousquet; Ioana Agache; Arnav Agarwal; Claus Bachert; Sinthia Bosnic-Anticevich; Romina Brignardello-Petersen; G. Walter Canonica; Thomas B. Casale; Niels H. Chavannes; Jaime Correia de Sousa; Alvaro A. Cruz; Carlos A. Cuello-Garcia; P. Demoly; Mark S. Dykewicz; Itziar Etxeandia-Ikobaltzeta; Ivan D. Florez; Wytske J. Fokkens; João Fonseca; Peter Hellings; Ludger Klimek; Sergio Kowalski; Piotr Kuna; Kaja-Triin Laisaar; Désirée Larenas-Linnemann; Karin C. Lødrup Carlsen; P. Manning; Eli O. Meltzer; Joaquim Mullol; Antonella Muraro

Collaboration


Dive into the Itziar Etxeandia-Ikobaltzeta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elie A. Akl

American University of Beirut

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maicon Falavigna

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge